Related Experiment Video

Updated: Aug 6, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic

A Richard Kitching1, Yao Z Kong, Xiao Ru Huang

  • 1Centre for Inflammatory Diseases, and Department of Medicine, Monash Medical Centre, Monash University, Clayton, Victoria, Australia.

Journal of the American Society of Nephrology : JASN
|May 23, 2003
PubMed

Insights

Plasminogen activator inhibitor-1 (PAI-1) significantly impacts crescentic glomerulonephritis. Reduced PAI-1 levels lessened kidney injury and fibrin deposition, while increased PAI-1 exacerbated these conditions.

Area of Science:

  • Nephrology
  • Immunology
  • Hematology

Background:

  • Crescentic glomerulonephritis involves glomerular fibrin deposition and is fibrin-dependent.
  • The fibrinolytic system counterbalances coagulation-driven fibrin deposition.
  • Plasminogen activator inhibitor-1 (PAI-1) inhibits fibrinolysis and influences inflammation and matrix deposition.

Purpose of the Study:

  • To investigate the role of Plasminogen activator inhibitor-1 (PAI-1) levels in determining the severity of crescentic glomerulonephritis.
  • To assess the impact of PAI-1 deficiency and overexpression on kidney injury markers.

Main Methods:

  • Accelerated anti-glomerular basement membrane glomerulonephritis was induced in mice.
  • Studies utilized PAI-1 deficient (PAI-1 -/-), heterozygous (PAI-1 +/-), and PAI-1 overexpressing (PAI-1 tg) mouse models.
  • Kidney tissues were analyzed for glomerular crescents, fibrin deposition, leukocyte infiltration, and collagen accumulation at 14 and 28 days.

Main Results:

  • PAI-1 -/- mice exhibited significantly reduced glomerular crescents, fibrin deposition, leukocyte infiltration, and renal collagen compared to controls.
  • PAI-1 tg mice showed increased glomerular crescent formation, fibrin deposition, leukocyte infiltration, and renal collagen at both time points.
  • These findings indicate PAI-1 is a critical factor in disease progression.

Conclusions:

  • Plasminogen activator inhibitor-1 (PAI-1) is a key determinant of glomerular fibrin deposition and renal injury in crescentic glomerulonephritis.
  • Modulating PAI-1 levels offers a potential therapeutic strategy for managing this kidney disease.

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Urokinase-type Plasminogen Activator-induced Mouse Back Pain Model06:20

Urokinase-type Plasminogen Activator-induced Mouse Back Pain Model

Published on: September 1, 2023

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...